Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRROR Open-Label Study of Pegloticase and Methotrexate in Uncontrolled Gout
NCT03635957Phase 4Completed
- Sponsor
- Amgen
- Start
- Sep 2018
- Primary completion
- Oct 2019
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegloticase in gout, sponsored by Amgen. Started Sep 2018; status: completed.
02
Drugs
pegloticase
03
Conditions
gout
Beyond the preview
Go deeper on NCT03635957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03635957.